Pancreatic Cancer Research

ResearcherBayer (Germany)No recent work listed

Arne Scholz Scholz

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5109212479. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper

Papers 2

  1. The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer. Co-author DOI 10.1038/bjc.2011.521↗
  2. Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer. Last author DOI 10.1096/fj.11-182287↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Petra M. Schulz · 2 shared papers, 2011–2012 · strength 0.06
  2. Bertram J. Wiedenmann · 2 shared papers, 2011–2012 · strength 0.06
  3. Katharina M Detjen · 2 shared papers, 2011–2012 · strength 0.06
  4. Noreen Otto · 1 shared paper, 2012 · strength 0.03
  5. Frauke Alves · 1 shared paper, 2011 · strength 0.02
  6. Christian Fischer · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.